SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (7814)3/31/2000 2:43:00 PM
From: Harold Engstrom  Read Replies (1) | Respond to of 9719
 
V1,

ABSC: Saw a $75MM convertible financing, but it looked like the $150MM share offering was cancelled. Did they raise more money than the $75MM?

H



To: Vector1 who wrote (7814)4/1/2000 11:09:00 AM
From: Spekulatius  Read Replies (1) | Respond to of 9719
 
CRA -
Celera hit probably the jackpot with this years spring biotech fundraiser: 4.37M shares @ 225$ each yielded net proceeds of 944M$.
GLIA stock price on reached 25$+ for a few days,so they did not have a window to raise capital. I would consider any public offering below 25$ ridiculous.

VRTX always was smart with financing. They raised capital in 1997. 3M shares @45.5$/share. Todays stock prices appears cheap.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News